Mercer Global Advisors Inc Crispr Therapeutics Ag Transaction History

Mercer Global Advisors Inc

$43 Billion
Q1 2025

A detailed history of Mercer Global Advisors Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mercer Global Advisors Inc holds 11,370 shares of CRSP stock, worth $625,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,370

Previous 9,980 13.93%

Holding current value

$625,350

Previous $392,000 1.53%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$34.03 - $53.02 $47,301 - $73,697	1,390 Added 13.93%	11,370 $386,000
Q4 2024 Feb 14, 2025	SELL	$38.65 - $55.15 $61,762 - $88,129	-1,598 Reduced 13.8%	9,980 $392,000
Q3 2024 Nov 13, 2024	BUY	$44.62 - $62.75 $35,294 - $49,635	791 Added 7.33%	11,578 $544,000
Q2 2024 Aug 12, 2024	BUY	$51.17 - $68.18 $22,872 - $30,476	447 Added 4.32%	10,787 $582,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $42,226 - $62,027	-696 Reduced 6.31%	10,340 $705,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $1,969 - $3,681	51 Added 0.46%	11,036 $691,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $17,929 - $23,305	395 Added 3.73%	10,985 $499,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $90,721 - $141,435	-2,087 Reduced 16.46%	10,590 $594,000
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $12,587 - $17,228	307 Added 2.48%	12,677 $573,000
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $5,369 - $8,996	137 Added 1.12%	12,370 $503,000
Q3 2022 Nov 15, 2022	SELL	$61.1 - $83.78 $56,212 - $77,077	-920 Reduced 6.99%	12,233 $799,000
Q2 2022 Aug 10, 2022	SELL	$43.23 - $73.83 $10,159 - $17,350	-235 Reduced 1.76%	13,153 $800,000
Q1 2022 May 10, 2022	BUY	$53.19 - $79.24 $452,061 - $673,460	8,499 Added 173.84%	13,388 $840,000
Q4 2021 Feb 04, 2022	BUY	$70.09 - $111.29 $50,044 - $79,461	714 Added 17.1%	4,889 $370,000
Q3 2021 Nov 10, 2021	BUY	$110.2 - $156.64 $94,221 - $133,927	855 Added 25.75%	4,175 $467,000
Q2 2021 Aug 10, 2021	BUY	$100.84 - $161.89 $37,512 - $60,223	372 Added 12.62%	3,320 $537,000
Q1 2021 May 11, 2021	BUY	$110.72 - $210.04 $42,405 - $80,445	383 Added 14.93%	2,948 $359,000
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $204,353 - $444,334	2,565 New	2,565 $393,000

Others Institutions Holding CRSP

# of Institutions

498

Shares Held

65.8M

Call Options Held

2.16M

Put Options Held

2.1M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.29B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Crispr Therapeutics Ag Transaction History